289 related articles for article (PubMed ID: 25080160)
1. Role of blood-brain barrier in temporal lobe epilepsy and pharmacoresistance.
van Vliet EA; Aronica E; Gorter JA
Neuroscience; 2014 Sep; 277():455-73. PubMed ID: 25080160
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin treatment during epileptogenesis in a rat model for temporal lobe epilepsy.
van Vliet EA; Holtman L; Aronica E; Schmitz LJ; Wadman WJ; Gorter JA
Epilepsia; 2011 Jul; 52(7):1319-30. PubMed ID: 21729039
[TBL] [Abstract][Full Text] [Related]
3. Why and how to target angiogenesis in focal epilepsies.
Morin-Brureau M; Rigau V; Lerner-Natoli M
Epilepsia; 2012 Nov; 53 Suppl 6():64-8. PubMed ID: 23134498
[TBL] [Abstract][Full Text] [Related]
4. Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy.
van Vliet EA; da Costa Araújo S; Redeker S; van Schaik R; Aronica E; Gorter JA
Brain; 2007 Feb; 130(Pt 2):521-34. PubMed ID: 17124188
[TBL] [Abstract][Full Text] [Related]
5. Blood-brain barrier dysfunction, seizures and epilepsy.
van Vliet EA; Aronica E; Gorter JA
Semin Cell Dev Biol; 2015 Feb; 38():26-34. PubMed ID: 25444846
[TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein imaging in temporal lobe epilepsy: in vivo PET experiments with the Pgp substrate [11C]-verapamil.
Feldmann M; Koepp M
Epilepsia; 2012 Nov; 53 Suppl 6():60-3. PubMed ID: 23134497
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy.
Rigau V; Morin M; Rousset MC; de Bock F; Lebrun A; Coubes P; Picot MC; Baldy-Moulinier M; Bockaert J; Crespel A; Lerner-Natoli M
Brain; 2007 Jul; 130(Pt 7):1942-56. PubMed ID: 17533168
[TBL] [Abstract][Full Text] [Related]
8. (R)-[11C]PK11195 brain uptake as a biomarker of inflammation and antiepileptic drug resistance: evaluation in a rat epilepsy model.
Bogdanović RM; Syvänen S; Michler C; Russmann V; Eriksson J; Windhorst AD; Lammertsma AA; de Lange EC; Voskuyl RA; Potschka H
Neuropharmacology; 2014 Oct; 85():104-12. PubMed ID: 24880085
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal assessment of blood-brain barrier leakage during epileptogenesis in rats. A quantitative MRI study.
van Vliet EA; Otte WM; Gorter JA; Dijkhuizen RM; Wadman WJ
Neurobiol Dis; 2014 Mar; 63():74-84. PubMed ID: 24321435
[TBL] [Abstract][Full Text] [Related]
10. Molecular neuropathology of temporal lobe epilepsy: complementary approaches in animal models and human disease tissue.
Majores M; Schoch S; Lie A; Becker AJ
Epilepsia; 2007; 48 Suppl 2():4-12. PubMed ID: 17571348
[TBL] [Abstract][Full Text] [Related]
11. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy.
Ravizza T; Gagliardi B; Noé F; Boer K; Aronica E; Vezzani A
Neurobiol Dis; 2008 Jan; 29(1):142-60. PubMed ID: 17931873
[TBL] [Abstract][Full Text] [Related]
12. Recent advances related to basic mechanisms of epileptogenesis.
Lowenstein DH
Epilepsy Res Suppl; 1996; 11():45-60. PubMed ID: 9294727
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms underlying blood-brain barrier dysfunction in brain pathology and epileptogenesis: role of astroglia.
Kovács R; Heinemann U; Steinhäuser C
Epilepsia; 2012 Nov; 53 Suppl 6():53-9. PubMed ID: 23134496
[TBL] [Abstract][Full Text] [Related]
14. The blood-brain barrier and epilepsy.
Oby E; Janigro D
Epilepsia; 2006 Nov; 47(11):1761-74. PubMed ID: 17116015
[TBL] [Abstract][Full Text] [Related]
15. A novel kindling model of temporal lobe epilepsy in rhesus monkeys induced by Coriaria lactone.
Hong Z; Yang TH; Tang MH; Zhang H; Li HX; Chen L; Chen Q; Zhou D
Epilepsy Behav; 2013 Dec; 29(3):457-65. PubMed ID: 24100251
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of novel bumetanide derivatives for epilepsy treatment.
Auer T; Schreppel P; Erker T; Schwarzer C
Neuropharmacology; 2020 Jan; 162():107754. PubMed ID: 31476353
[TBL] [Abstract][Full Text] [Related]
17. Molecular profiling of temporal lobe epilepsy: comparison of data from human tissue samples and animal models.
Majores M; Eils J; Wiestler OD; Becker AJ
Epilepsy Res; 2004; 60(2-3):173-8. PubMed ID: 15380561
[TBL] [Abstract][Full Text] [Related]
18. Activation of the innate immune system is evident throughout epileptogenesis and is associated with blood-brain barrier dysfunction and seizure progression.
Broekaart DWM; Anink JJ; Baayen JC; Idema S; de Vries HE; Aronica E; Gorter JA; van Vliet EA
Epilepsia; 2018 Oct; 59(10):1931-1944. PubMed ID: 30194729
[TBL] [Abstract][Full Text] [Related]
19. Treatment with melatonin after status epilepticus attenuates seizure activity and neuronal damage but does not prevent the disturbance in diurnal rhythms and behavioral alterations in spontaneously hypertensive rats in kainate model of temporal lobe epilepsy.
Petkova Z; Tchekalarova J; Pechlivanova D; Moyanova S; Kortenska L; Mitreva R; Popov D; Markova P; Lozanov V; Atanasova D; Lazarov N; Stoynev A
Epilepsy Behav; 2014 Feb; 31():198-208. PubMed ID: 24440891
[TBL] [Abstract][Full Text] [Related]
20. Drug resistance and hippocampal damage after delayed treatment of pilocarpine-induced epilepsy in the rat.
Chakir A; Fabene PF; Ouazzani R; Bentivoglio M
Brain Res Bull; 2006 Dec; 71(1-3):127-38. PubMed ID: 17113938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
